Suscribirse

A Project ECHO and Community Health Worker Intervention for Patients with Diabetes - 04/05/22

Doi : 10.1016/j.amjmed.2021.12.002 
Saul Blecker, MD, MHS a, b, , Margaret M. Paul, PhD a, Simon Jones, PhD a, John Billings, JD c, Matthew F. Bouchonville, MD d, e, Brant Hager, MD e, f, Sanjeev Arora, MD d, e, Carolyn A. Berry, PdD a
a Department of Population Health, NYU Grossman School of Medicine, New York, NY 
b Department of Medicine, NYU Grossman School of Medicine, New York, NY 
c Wagner School of Public Service, New York University, New York, NY 
d Department of Medicine, University of New Mexico School of Medicine, Albuquerque 
e ECHO Institute, University of New Mexico Health Sciences Center, Albuquerque 
f Department of Psychiatry and Behavioral Sciences, University of New Mexico School of Medicine, Albuquerque 

Requests for reprints should be addressed to Saul Blecker, MD, MHS, NYU Grossman School of Medicine, 227 E. 30th St., 6th Floor, New York, NY, 10016.NYU Grossman School of Medicine227 E. 30th St., 6th FloorNew YorkNY,10016

Abstract

Background

Both community health workers and the Project ECHO model of specialist telementoring are innovative approaches to support primary care providers in the care of complex patients with diabetes. We studied the effect of an intervention that combined these 2 approaches on glycemic control.

Methods

Patients with diabetes were recruited from 10 federally qualified health centers in New Mexico. We used electronic health record (EHR) data to compare HbA1c levels prior to intervention enrollment with HbA1c levels after 3 months (early follow-up) and 12 months (late follow-up) following enrollment. We propensity matched intervention patients to comparison patients from other sites within the same electronic health records databases to estimate the average treatment effect.

Results

Among 557 intervention patients with HbA1c data, mean HbA1c decreased from 10.5% to 9.3% in the pre- versus postintervention periods (P < .001). As compared to the comparison group, the intervention was associated with a change in HbA1c of −0.2% (95% confidence interval [CI] −0.4%-0.5%) and −0.3 (95% CI −0.5–0.0) in the early and late follow-up cohorts, respectively. The intervention was associated with a significant increase in percentage of patients with HbA1c <8% in the late follow-up cohort (8.1%, 95% CI 2.2%−13.9%) but not the early follow-up cohort (3.6%, 95% CI −1.5% to 8.7%)

Discussion

The intervention was associated with a substantial decrease in HbA1c in intervention patients, although this improvement was not different from matched comparison patients in early follow-up. Although combining community health workers with Project ECHO may hold promise for improving glycemic control, particularly in the longer term, further evaluations are needed.

El texto completo de este artículo está disponible en PDF.

Keywords : Diabetes, Primary care, Project ECHO


Esquema


 Funding: This study was supported by The Leona M. and Harry B. Helmsley Charitable Trust.
 Conflicts of Interest: None.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 135 - N° 5

P. e95-e103 - mai 2022 Regresar al número
Artículo precedente Artículo precedente
  • Effects of Repeated Co-Injections of Corticosteroids and Hyaluronic Acid on Knee Osteoarthritis: A Prospective, Double-Blind Randomized Controlled Trial
  • Chun-Ping Wang, Wen-Chung Lee, Ru-Lan Hsieh
| Artículo siguiente Artículo siguiente
  • Chronic Summer-Type Hypersensitivity Pneumonitis Presenting as Anorexia and Weight Loss
  • Yasuhiro Kano, Yu Sato

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.